CymaBay Therapeutics (CBAY) Earnings Date, Estimates & Call Transcripts → Biden’s Tax Plan Could Destroy Your Retirement Savings! (From GoldenCrest Metals) (Ad) Free CBAY Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrends Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCBAY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CBAY Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyTop-Secret Government Project RevealedDetails a top-secret program for taking America’s most critical technology mainstream. And it has nothing to do with artificial intelligence, cryptocurrency, or the blockchain.To get all the details of this new tech – click here now. CymaBay Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($0.35)($0.23)($0.30)Q2 20243($0.40)($0.24)($0.34)Q3 20243($0.47)($0.24)($0.38)Q4 20243($0.53)($0.24)($0.38)FY 202412($1.75)($0.95)($1.41) Get CymaBay Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for CBAY and its competitors with MarketBeat's FREE daily newsletter. CymaBay Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript2/28/2024Q4 2023($0.31)($0.35)($0.04)($0.35)$0.42 million$0.06 million11/7/2023Q3 2023($0.30)($0.32)($0.02)($0.32)$0.22 million- 8/10/2023Q2 2023($0.21)($0.01)+$0.20($0.01)$30.78 million$31.02 million 5/15/2023Q1 2023($0.16)($0.29)($0.13)($0.29)--3/16/2023Q4 2022($0.30)($0.30)-($0.30)-- 11/14/2022Q3 2022($0.30)($0.28)+$0.02($0.28)-- Get the Latest News and Ratings for CBAY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CymaBay Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/11/2022Q2 2022($0.30)($0.31)($0.01)($0.31)-- 5/12/2022Q1 2022($0.31)($0.32)($0.01)($0.32)-- 3/17/2022Q4 2021($0.36)($0.34)+$0.02($0.34)-- 11/10/2021Q3 2021($0.26)($0.33)($0.07)($0.33)-- 8/12/2021Q2 2021($0.27)($0.34)($0.07)($0.34)-- 5/13/2021Q1 2021($0.24)($0.25)($0.01)($0.25)-- 3/24/2021Q4 2020($0.20)($0.23)($0.03)($0.23)-- 11/5/2020Q3 2020($0.17)($0.17)-($0.17)-- 8/10/2020Q2 2020($0.23)($0.16)+$0.07($0.16)-- 5/11/2020Q1 2020($0.31)($0.19)+$0.12($0.19)-- 3/12/2020Q4 2019($0.39)($0.43)($0.04)($0.28)-- 11/5/2019Q3($0.37)($0.38)($0.01)($0.38)-- 8/7/2019Q2 2019($0.37)($0.35)+$0.02($0.35)-- CymaBay Therapeutics Earnings - Frequently Asked Questions How much revenue does CymaBay Therapeutics generate each year? CymaBay Therapeutics (NASDAQ:CBAY) has a recorded annual revenue of $31.07 million. How much profit does CymaBay Therapeutics generate each year? CymaBay Therapeutics (NASDAQ:CBAY) has a recorded net income of -$105.37 million. CBAY has generated -$0.97 earnings per share over the last four quarters. What is CymaBay Therapeutics's EPS forecast for next year? CymaBay Therapeutics's earnings are expected to grow from ($1.38) per share to ($1.37) per share in the next year. More Earnings Resources from MarketBeat Related Companies: MIRM Earnings CDMO Earnings RIGL Earnings GTHX Earnings VTRS Earnings UTHR Earnings RDY Earnings SRPT Earnings CTLT Earnings ELAN Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple Stock All-Time Highs: Can AI Outweigh Earnings Jitters?CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry Shifts This page (NASDAQ:CBAY) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersGold Prices Surge and This $0.32 Stock Is Reaping The RewardsGold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially ...Market JAR | SponsoredMoonshot Coins for the Current Crypto RunAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredAn utter travestyThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CymaBay Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CymaBay Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.